The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Perspective: Generic Drug approvals in the US Prior to the Hatch-Waxman Act

Perspective: Generic Drug approvals in the US Prior to the Hatch-Waxman Act

Posted 01 September 2008

It is a common misconception that the Hatch-Waxman Act of 19841 created the generic drug approval process in the US. A recent article claimed there were few generic drugs approved in the US before that act was passed.2

 

© 2021 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe